Article

ACC 2011-- Morten Schou, MD, PhD for the Danish Heart Failure Study

Author(s):

Dr. Morten Schou discusses the Danish Heart Failure Study and the conclusion that the researchers came up with upon evaluating the results.

Clyde Yancy, MD, FAHA, and Morten Schou, MD, PhD, spoke at the ACC 2011 meeting about the Danish Heart Failure Study. Schou, a cardiologists at one of the Copenhagen Medical Centers in Denmark discusses the findings from the study and the conclusions that the researchers came up with upon evaluating the results.

To start of with the discussion, Yancy said, "We have an ongoing questions in heart failure about hwo important it is to augment ordinary and standard therapy with either disease management as delivered by heart failure clinics, subspecialty clinics if you will. And or to overlay that process with either the risk strateficiation afforded by the assignment of biomarkers like anti pro-BNP possibly even including managing patients aggressively titrating thearpies according to the anti pro-BNP levels. Those are a lot of new wrinkles in the way we were considering taking care of patients with heart failure, but obviously all of these decisions need to be delivered by evidence."

Source:

AHAScienceNews

Related Videos
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Looking Deeper into Genetic Variants of FSGS, with Jennifer Lai Yee, MD, PhD, MPH
Ladan Zand, MD: Evaluating Obinutuzumab in Primary FSGS and Further Research
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
© 2024 MJH Life Sciences

All rights reserved.